泰格医药

- 300347

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
泰格医药(300347) 利润表
单位:万元
报表日期2023-12-312023-09-302023-06-302023-03-312022-12-31
一、营业总收入738,403.95565,047.79371,085.04180,457.14708,547.15
营业收入738,403.95565,047.79371,085.04180,457.14708,547.15
二、营业总成本555,412.47414,218.66272,002.55136,029.14515,654.41
营业成本453,551.06337,092.01222,976.35108,904.89427,700.76
营业税金及附加2,786.672,143.601,480.48684.952,301.87
销售费用18,731.4813,270.368,899.844,491.1114,989.04
管理费用65,020.1452,754.3134,647.1017,092.3663,013.19
财务费用-10,832.40-10,575.94-8,809.46-1,596.11-15,812.38
研发费用26,155.5119,534.3212,808.256,451.9423,461.93
资产减值损失----------
公允价值变动收益35,277.0671,039.4352,975.7617,641.2753,585.73
投资收益33,817.5312,773.549,890.212,578.4710,275.07
其中:对联营企业和合营企业的投资收益10,518.30--6,372.44--3,976.25
汇兑收益----------
三、营业利润248,694.06231,172.43159,859.7863,089.78258,239.85
加:营业外收入1,345.40687.11454.9784.801,129.91
减:营业外支出1,186.15412.59400.2468.37832.02
其中:非流动资产处置损失----------
四、利润总额248,853.31231,446.94159,914.5163,106.21258,537.74
减:所得税费用33,860.6228,662.2419,105.516,273.6531,365.20
五、净利润214,992.68202,784.70140,809.0056,832.57227,172.54
归属于母公司所有者的净利润202,485.00187,960.44138,833.7056,845.51200,655.20
少数股东损益12,507.6914,824.251,975.30-12.9426,517.34
六、每股收益
基本每股收益(元/股)2.34002.17001.61000.66002.3200
稀释每股收益(元/股)2.34002.17001.61000.66002.3200
七、其他综合收益5,351.616,697.0710,316.31-4,655.3930,330.00
八、综合收益总额220,344.29209,481.77151,125.3152,177.18257,502.55
归属于母公司所有者的综合收益总额206,283.31192,104.26145,820.7553,759.46222,809.59
归属于少数股东的综合收益总额14,060.9817,377.515,304.56-1,582.2834,692.96
下载全部历史数据到excel中 返回页顶